GGrantIndex
Sort

46,585 grants matching heart failure

Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life

$827,451
Sharmila Dorbala · Brigham And Women'S Hospital · R01 · FY2023 · HL

A Developmental Approach to Testing Suicidal Phenotypes in Early Childhood in Black Youth

$827,404
Stephanie D Stepp · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · MH

Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis

$827,356
Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL

Imaging Histone Deacetylase in the Heart and Bone Marrow

$827,290
David E Sosnovik · Massachusetts General Hospital · R01 · FY2018 · HL

Translational studies in Heart Failure Gene Therapy

$827,256
Charles R Bridges · University Of Pennsylvania · R01 · FY2009 · HL

PEDIATRIC CARDIOMYOPATHY REGISTRY

$827,211
University Of Rochester · R01 · FY2002 · HL

Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure

$827,104
Robert Morris Blanton · Tufts Medical Center · R01 · FY2024 · HL

Assessment of Mast Cell Degranulation in Infarcted Myocardium Using Quantitative Multiparametric MRI

$826,892
Debiao Li · Cedars-Sinai Medical Center · R01 · FY2023 · HL

Assessment of Mast Cell Degranulation in Infarcted Myocardium Using Quantitative Multiparametric MRI

$826,892
Debiao Li · Cedars-Sinai Medical Center · R01 · FY2025 · HL

Mechanisms underlying the blood pressure lowering effect of sleep extension.

$826,770
Janet M Mullington · Beth Israel Deaconess Medical Center · R01 · FY2020 · HL

Molecular Characterization of Progressive Pulmonary Sarcoidosis

$826,678
Lisa A Maier · National Jewish Health · R01 · FY2023 · HL

Imaging Histone Deacetylase in the Heart and Bone Marrow

$826,447
David E Sosnovik · Massachusetts General Hospital · R01 · FY2021 · HL

Imaging Histone Deacetylase in the Heart and Bone Marrow

$826,447
David E Sosnovik · Massachusetts General Hospital · R01 · FY2020 · HL

Imaging Histone Deacetylase in the Heart and Bone Marrow

$826,447
David E Sosnovik · Massachusetts General Hospital · R01 · FY2019 · HL

Effects of a Pulse Induced by a Constant-Flow Total Cardiac Replacement Device

$826,447
O. H. Frazier · Texas Heart Institute · R01 · FY2009 · HL

Animal Model of Ethanol-Induced Cardiomyopathy

$826,316
Gwathmey, Inc. · R44 · FY2004 · AA

Cocaine HIV/AIDS, and Antiretrovirals

$826,241
William Lewis · Emory University · R01 · FY2014 · DA

Novel PET/CT and Treatment Strategies to reduce PTS following DVT

$826,096
Farouc Amin Jaffer · Massachusetts General Hospital · R01 · FY2018 · HL

Machine learning for the automated identification and tracking of rare myocardial diseases

$826,025
Rahul Chandrakant Deo · University Of California, San Francisco · R01 · FY2018 · HL

Finding undiagnosed ATTR-CM patients using AI technology in clinical settings

$825,902
Kelly D Myers · Atomo, Inc · R44 · FY2024 · HL

TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial

$825,573
Joerg Herrmann · Mayo Clinic Rochester · R01 · FY2022 · CA

NIH Director's Pioneer Award

$825,143
George Q Daley · Boston Children'S Hospital · DP1 · FY2007 · OD

NIH Director's Pioneer Award

$825,143
George Q Daley · Boston Children'S Hospital · DP1 · FY2008 · OD

REMATCH TRIAL

$825,070
Columbia University Health Sciences · U01 · FY2000 · HL

q4DE: A Biomarker for Image-Guided, Post-MI Hydrogel Therapy

$824,785
James S Duncan · Yale University · R01 · FY2019 · HL